Press
REXIS BIOTECH ANNOUNCES STRATEGIC PARTNERSHIP WITH SUBCULTURE COFFEE
Dover, Delaware – Dec 14, 2023 – Rexis Biotech Inc. (“REXIS”) is delighted to announce its continued growth and expansion into new markets through a
REXIS BIOTECH ANNOUNCES STRATEGIC PARTNERSHIP WITH 3CHI & WEFUNDER CROWDFUNDING EQUITY RAISE
Dover Delaware – July 13, 2023 – Rexis Biotech Inc. (“REXIS”) is delighted to announce its continued growth and expansion into new markets through a
REXIS BIOTECH UPDATES STRATEGIC PARTNERSHIP AGREEMENT WITH MICHIGAN CANNABIS RETAILER REDBUD ROOTS
Dover, Delaware – April 3, 2023 – Rexis Biotech Inc. (“REXIS”) is pleased to announce its continued growth and expansion into the legal cannabis markets
REXIS BIOTECH ANNOUNCES STRATEGIC LONG-TERM PARTNERSHIP WITH MASSACHUSETTS CANNABIS RETAILER HAPPY VALLEY
Dover, Delaware – March 22, 2023 – Rexis Biotech Inc. (“REXIS”) is pleased to announce its continued growth and expansion into the legal cannabis markets
REXIS BIOTECH ANNOUNCES THE OFFICAL APPROVAL AND LAUNCH OF IT’S FUSED POLYMPORPH NANO FIBER TECHNOLOGY
Dover, Delaware – March 16, 2023 – Rexis Biotech Inc. (“REXIS”) is delighted to announce that, after more than three years of development and clinical
